Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001224634 | SCV001396846 | pathogenic | Deficiency of ferroxidase | 2022-12-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 952512). This variant has not been reported in the literature in individuals affected with CP-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.005%). This sequence change creates a premature translational stop signal (p.Tyr890*) in the CP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CP are known to be pathogenic (PMID: 16629161). |
Revvity Omics, |
RCV001224634 | SCV002019713 | pathogenic | Deficiency of ferroxidase | 2020-08-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004570545 | SCV005050641 | pathogenic | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | CP: PVS1, PM2 |